reduce basal insulin dose when starting glp-1 receptor agonist Approaches for initiating insulin. OD: Once daily; BID: Twice daily; Should a patient stop their

HONESTY AND INTEGRITY are highly valued

Genuine patients, who would benefit tremendously from these drugsdiabetics or obese individuals with comorbiditiesmay shun these drugs, for fear of side effects

However, during the chronic inflammation, the glial activation causes an increase of ROS production and other neurotoxic mediators, leading a neuronal damage [52]

doi:10.1007/s10753-018-00954-3 99

Niacin, at pharmacologic doses, has historically been used to modify lipid profiles, though current guidelines no longer routinely recommend it for cardiovascular risk reduction

MH: Conceptualization, Funding acquisition, Project administration, Supervision, Writing review & editing